an insulin device , novopen , incorporating human actrapid insulins was used in a group of 6 poor -- controlled diabetic adolescents , aged 15 years ( mean 8-18.7 ) with duration of diabetes 8.2 +/- 4.8 years ( mean +/- s.d ) .
C0021641
insulin
C0795635
human